PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹559 Cr | ₹559 Cr | ₹460 Cr | ₹661 Cr | ₹625 Cr |
What is the latest Revenue of PANACEA BIOTEC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹559 Cr |
| Mar2024 | ₹559 Cr |
| Mar2023 | ₹460 Cr |
| Mar2022 | ₹661 Cr |
| Mar2021 | ₹625 Cr |
How is Revenue of PANACEA BIOTEC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹559 Cr | -0.01 | |
| Mar2024 | ₹559 Cr | 21.57 | |
| Mar2023 | ₹460 Cr | -30.44 | |
| Mar2022 | ₹661 Cr | 5.83 | |
| Mar2021 | ₹625 Cr | - | |
Compare Revenue of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,230.7 Cr | -0.6% | -5.2% | 3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -0.6% |
-5.2% |
3.2% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses